Charles River (CRL) Laboratories and BioTech Social announced the exploration of a potential client-centric collaboration to enable Charles River Incubator and Accelerator Program participants to access the BioTech Funding Portal. If formalized, the partnership would allow early-stage cell and gene therapy developers to raise up to $5M per year via the platform. The BioTech Funding Portal exclusively lists life sciences companies, acting as a conduit for crowdfunding.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
